http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002509889-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65 |
| filingDate | 1999-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002509889-A |
| titleOfInvention | Method for inhibiting membrane matrix metalloproteinase |
| abstract | (57) [Summary]n The present invention is a method for inhibiting membrane-type matrix metalloproteinase (MT-MMP) activity in a biological system. Accordingly, the present invention allows for the treatment of medical conditions in mammals characterized by MT-MMP activity, particularly those characterized by excessive MT-MMP activity. The method comprises a tetracycline compound, preferably a non-antibacterial tetracycline, more preferably 6-demethyl-6-deoxy-4-de (dimethylamino) tetracycline (CMT-3) or 6-α-deoxy-5-hydroxy-4-. De- (dimethylamino) tetracycline (CMT-8) is used to inhibit MT-MMP activity. |
| priorityDate | 1998-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 199.